Ireland· IE-PA-EU/1/25/1999/001
VacPertagen suspension for injection in pre-filled syringe Pertussis vaccine (recombinant, acellular, component, adsorbed)
A pertussis, gereinigtes antigen (azellulär) product containing pertussis filamentous haemagglutinin, registered in Ireland by Bionet Europe. The same ATC class is registered in 8 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Pertussis, gereinigtes antigen (azellulär) is registered in 8 of 19 countries.
Countries holding a registration under ATC J07AJ02 (pertussis, gereinigtes antigen (azellulär)), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Pertussis, gereinigtes antigen (azellulär) · ATC J07AJ02
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
HPRA (Ireland)- Active substance
- PERTUSSIS FILAMENTOUS HAEMAGGLUTININ
- Manufacturer
- Bionet Europe
- Country
- Ireland (IE)
- ATC code
- J07AJ02
- ATC class
- Pertussis, gereinigtes Antigen (azellulär)
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/25/1999/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AJ02
Pertussis, gereinigtes antigen (azellulär), as other registers publish it.
- FinlandVacPertagenBioNet Europe
- IcelandVacPertagenBionet Europe
- BelgiumVacPertagenBioNet Europe
- DenmarkVacPertagenBionet Europe
- PolandVacPertagenBioNet Europe
- CzechiaVACPERTAGENBioNet Europe SAS, Lyon
- NetherlandsVacPertagen suspensie voor injectie in een voorgevulde spuit Pertussisvaccin (recombinant, acellulair, component, geadsorbeerd)Bionet Europe
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e4653d1c-e72b-4435-bb69-477d697ea454 GET /v1/drugs/e4653d1c-e72b-4435-bb69-477d697ea454?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Suspension for injection in pre-filled syringe",
"routes": [
"Intramuscular use"
],
"source": "hpra",
"atc_all": [
"J07AJ02"
],
"strength": null,
"pa_number": "EU/1/25/1999/001",
"substances": [
"PERTUSSIS FILAMENTOUS HAEMAGGLUTININ"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "09/01/2026",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about pertussis, gereinigtes antigen (azellulär).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.